Weight Loss Drugs

National Women’s Health Network Urges Women to Resist “Cheap” Gimmicks for Losing Weight in the New Year

By NWHN Staff | Jan 7, 2016 | Comments Off on National Women’s Health Network Urges Women to Resist “Cheap” Gimmicks for Losing Weight in the New Year

FOR IMMEDIATE RELEASE

Contact: Christina Cherel at ccherel@nwhn.org or 202.682.2640, ext 224

“Free” Diet Drugs That Cost You in the Long Run

By NWHN Staff | Jan 7, 2016 | Comments Off on “Free” Diet Drugs That Cost You in the Long Run

With the New Year often comes resolutions to lead happier – and healthier – lives.

Weight Loss

By NWHN Staff | Aug 14, 2015 | Comments Off on Weight Loss

Quick-fix weight loss remedies have always been popular, but they’ve gained even more momentum in recent years due to increased attention to the rising rates of obesity in the United States. Anti-obesity drugs are often touted as “miracle products” that yield results with minimal effort.

Is a Lower Number Worth a Higher Risk?

By NWHN Staff | Mar 27, 2015 | Comments Off on Is a Lower Number Worth a Higher Risk?

Imagine taking a pill, stepping on your scale, and seeing a lower number — just like that, and just in time for Spring’s warmer weather. Now, imagine that lower number coming at a heavy price — and not just the money you’ll spend on your weight loss drug’s prescription. Would you be willing to take the risk?

New Year, Same Old Miracle Drug Spin

By NWHN Staff | Jan 7, 2015 | Comments Off on New Year, Same Old Miracle Drug Spin

The holiday season is over and as usual, many people are feeling motivated to lose weight and live healthier. But for the one-third of Americans struggling with obesity, this struggle just gets harder and harder, especially as we age. For many, a safe and effective weight loss pill would seem like the magic bullet we so desperately need.

FDA Meeting – Lorcaserin

By NWHN Staff | May 10, 2012 | Comments Off on FDA Meeting – Lorcaserin

Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Meeting on Lorcaserin

FDA Meeting – Qnexa Safety and Efficacy

By NWHN Staff | Feb 22, 2012 | Comments Off on FDA Meeting – Qnexa Safety and Efficacy

Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee Meeting

FDA Meeting – Naltrexone/Bupropion (Contrave)

By NWHN Staff | Dec 7, 2010 | Comments Off on FDA Meeting – Naltrexone/Bupropion (Contrave)

Food and Drug Administration (FDA) Gastroenterology Endocrinologic and Metabolic Drugs Advisory Committee